Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
... cells of the innate immune system, neutrophils and monocytes/macrophage, enabling them to recognize and kill antibody-targeted cancer cells.
Anti-tumour activity of the immune system is an important intrinsic tumour suppressor mechanism that various tumour immunotherapy approaches aim ...
The investigator-sponsored trial is being conducted at the Fred Hutchinson Cancer Research Center. ... The combination of intra-tumoral G100 with local radiation is expected to boost the immune system's response to tumor antigens ...
Both ADXS-HPV and epacadostat are investigational cancer immunotherapies, a new class of treatments that use the body's own immune system to ...
The mortality of pancreatic cancer is high, making it the fourth deadliest cancer for both men and women across the European Union.3 Patients ...
... the UK to make a new drug available to patients with a rare form of cancer. ... including the drug Abraxane as a new treatment for pancreatic cancer.
"My chances of getting cancer - a bad lung cancer - were very good," she said. "My mother died of pancreatic cancer. I feel like maybe I was inclined to ...
“We are proud to take part in a clinical trial testing a novel approach for the treatment of pancreatic cancer,” said Dr. Fernando Rivera, senior medical ...
Adjuvant chemotherapy (ACT) after radical cystectomy for bladder cancer is associated with better cancer-specific and overall survival regardless of ...
Liquid biopsy tests for breast and bladder cancer are currently in clinical studies, with the hopes of launching the first liquid biopsy test next year.
Bladder cancer ranks in the top four treated tumors for all five countries. It ranks second in Italy (15%) and Spain (13.2%); this is influenced by a wide ...
“We've known for many years that noninvasive bladder cancer is influenced substantially by immunotherapeutics, but it's now beginning to look like ...
Both ADXS-HPV and epacadostat are investigational cancer immunotherapies, a new class of treatments that use the body's own immune system to ...
The research center is working toward applying immunotherapy cancer ... which reprograms T-cells to boost the immune system and fight off cancer.
"This construct may provide the benefit of combination immunotherapy ... New knowledge in the field of cancer immunotherapy, combined with new ...
... III head and neck cancer trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection) in the Philippines.
Pancreatic Ductal Adenocarcinoma (PDAC) is the most common form of pancreatic cancer with high mortality and a 5-year survival rate <5 o:p="">
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, ...
The decision follows the recent NHS England announcement to defer their review of ABRAXANE® for metastatic pancreatic cancer, allowing the ...
Significant weight loss if you haven't changed your diet or physical activities could signal cancer of the lungs, stomach or pancreas. See your doctor if ...
Inhibiting Bone Turnover Could Prevent Bone Mets in Breast Cancer
An inhibitor of osteoclast formation can stop the proliferation of dormant tumor cells that in some breast cancer survivors turn into bone metastases.
An inhibitor of osteoclast formation can stop the proliferation of dormant tumor cells that in some breast cancer survivors turn into bone metastases.
Ovarian Cancer Disease Burden Affects Survival Despite R0 Resection
Despite achieving complete surgical resection, advanced epithelial ovarian cancer or primary peritoneal cancer patients with a high disease burden had worse survival outcomes than those with lower disease burden.
Despite achieving complete surgical resection, advanced epithelial ovarian cancer or primary peritoneal cancer patients with a high disease burden had worse survival outcomes than those with lower disease burden.
Two Distinct Subtypes of Pediatric Glioma Identified
Researchers have identified two genetic characteristics that may distinguish pediatric secondary high-grade glioma from primary high-grade glioma.
Researchers have identified two genetic characteristics that may distinguish pediatric secondary high-grade glioma from primary high-grade glioma.
Many Women Willing to Extend Cervical Cancer Screening Intervals
Women in routine gynecologic care expressed willingness to extend screening intervals and use cytology alone or Pap-HPV cotesting if recommended by a physician.
Women in routine gynecologic care expressed willingness to extend screening intervals and use cytology alone or Pap-HPV cotesting if recommended by a physician.
Conservative Approach to CIN 2 a Good Option in Young Women
Conservative management of cervical intraepithelial neoplasia (CIN) grade 2 is an appropriate treatment option for women aged 25 years and younger.
Conservative management of cervical intraepithelial neoplasia (CIN) grade 2 is an appropriate treatment option for women aged 25 years and younger.
Real-Time Mobile App Improved Some Sun-Protection Behaviors
Two studies published recently showed that the use of a smartphone application was able to improve certain sun protection behaviors among study participants.
Two studies published recently showed that the use of a smartphone application was able to improve certain sun protection behaviors among study participants.
Science Daily Cancer News
Silibinin from milk thistle seeds could be a novel, non-invasive treatment strategy for Cushing Disease. Cushing Disease, not to be confused with Cushing's Syndrome, is caused by a tumor in the pituitary gland in the brain.
New research has some scientists wondering if the entire study of cellular biology needs to be adjusted. Researchers made the discovery that mitochondria are capable of passing through the healthy membrane of a host cell into defective tumor cells, possibly kicking off the rapid proliferation of tumour cells which is the hallmark of cancer. Until now each cell was believed to be a unique entity, with mitochondria and mitochondrial DNA (mtDNA) bound within the cell membrane. New research has found this mtDNA is capable of moving from a healthy cell to a dysfunctional tumor cell.
Tambahkan Komentar